Ryerson Holding Corp (RYI) officer reports dividend-equivalent RSU awards

Rhea-AI Filing Summary

Ryerson Holding Corp’s chief accounting officer and corporate controller reported new equity awards tied to the company’s dividend payments. On December 18, 2025, the insider received additional restricted stock units (RSUs) in the form of dividend equivalent rights at no cash cost, recorded at a price of $0 per unit. These derivative awards cover common stock and are shown in three separate RSU entries of 15.033, 29.404, and 48.643 units, each linked to earlier RSU grants.

The filing explains that each RSU represents the right to receive one share of Ryerson common stock, and that dividend equivalent rights accrue when dividends are paid and vest on the same schedule as the underlying RSUs. The rights reported here relate to RSUs originally granted on March 31, 2023, March 31, 2024, and March 31, 2025, which are scheduled to vest between March 31, 2026 and March 31, 2028.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kannan Molly D

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO & Corporate Controller

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/18/2025		A		15.033(2)		(3)	(3)	Common Stock	15.033	$0	2,089.852	D
Restricted Stock Units	(1)	12/18/2025		A		29.404(2)		(4)	(4)	Common Stock	29.404	$0	4,087.901	D
Restricted Stock Units	(1)	12/18/2025		A		48.643(2)		(5)	(5)	Common Stock	48.643	$0	6,762.591	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Ryerson Holding Corp (RYI) report in this Form 4?

The filing shows the chief accounting officer and corporate controller acquired additional restricted stock units (RSUs) as dividend equivalent rights on December 18, 2025, tied to existing RSU awards and recorded at a price of $0 per unit.

How many new restricted stock units were reported by the Ryerson (RYI) insider?

The filing lists three new RSU entries of 15.033, 29.404, and 48.643 units. Each entry represents dividend equivalent rights that correspond to earlier RSU grants and are settled in Ryerson common stock.

What are the dividend equivalent rights described in the Ryerson (RYI) Form 4?

The dividend equivalent rights represent additional RSUs that accrue when and as dividends are paid on the common shares underlying the original RSUs. They vest proportionately and are subject to the same settlement and expiration terms as the underlying restricted stock units.

Which prior RSU grants do these dividend equivalent rights for Ryerson (RYI) relate to?

The dividend equivalent rights accrued on RSUs originally granted on March 31, 2023, March 31, 2024, and March 31, 2025. These prior grants were still outstanding as of December 18, 2025.

When will the reported Ryerson (RYI) RSUs and related dividend equivalents vest?

The filing states that the unvested RSUs and their related dividend equivalent rights will vest on March 31, 2026 for the 2023 grant, on March 31, 2026 and March 31, 2027 for the 2024 grant, and on March 31, 2026, March 31, 2027 and March 31, 2028 for the 2025 grant.

Did the Ryerson (RYI) insider pay cash for these new RSUs?

No. The derivative securities in the filing, described as restricted stock units with dividend equivalent rights, are shown with a price of $0, indicating they were awarded rather than purchased in the open market.